Pharmaceutical Excipients Market Size To Reach USD 10.15 Billion By 2027 – Top Key Players Ashland Global Holdings, BASF SE, DuPont

The rise in the number of diseases globally, the development of new drugs, technological advances for formulations ongoing new product launches, and strategic collaboration, awareness among people for better healthcare facilities are key factors contributing to the high CAGR of the Pharmaceutical Excipients market during the forecast period.

According to the current analysis of Reports and Data, the global Pharmaceutical Excipients Market valued at USD 6.53 billion in 2019 and is expected to reach USD 10.15 billion by the year 2027, at a CAGR of 5.7%. Excipients are the products that do not show any activity of the drug but facilitates the drug delivery process. The increase in the outbreak of pandemic or epidemic diseases across the globe is the primary factor for boosting the growth of the market. The problems associated with instability, poor solubility, and absorption of active pharmaceutical ingredients are driving the demand for pharmaceutical excipients. The development of nanotechnology for the administration of drugs is further boosting the growth of the market. In 2015, the amount of manufacturing of final products of drugs in Japan accounted for 6,820.4 billion yen, the amount of import was 4,022 billion yen. Increasing outbreak of life threatening diseases and increasing incidences of resistance over traditional treatment plan resulting in increasing number of final production are expected to boost the market growth.

North America has obtained remarkable growth in the market due to the awareness among the consumers for better healthcare, government initiatives for research and development of new drugs, clinical trials, and due to better facilities for healthcare in the region. However, the high cost of drug development is the primary restraint to market growth.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2713

Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.

The report has gather vital information about recent mergers and acquisitions, joint ventures, collaborations, partnerships, brand promotions, R&D activities, and government and corporate deals, among others through extensive primary and secondary research. The report also offers detailed analysis of each competitor along with their financial standing, global market position, product portfolio, manufacturing and production capacity, and business expansion plans.

The report offers a comprehensive overview of the regional bifurcation of the market with respect to market share, market size, revenue growth, import/export, production and consumption patterns, macro and micro economic growth factors, regulatory framework, investment and funding opportunities, and presence of key players in each region including North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. The report offers a country-wise analysis to further discuss the revenue growth and lucrative growth opportunities for the Pharmaceutical Excipients market in these key regions.

Further key findings from the report suggest

• Croda International, in the year 2018 had launched Moonshine Effect Pigments, it is a range of borosilicate-based effect pigments, it is specially designed for personal care products, the quality borosilicate substrate produces the effect exceptional vibrancy, intensity, and color transmission for eye-catching results in cosmetic formulations.

• JRS Pharma had received an EXCiPACT Certificate from DQS for the production of Microcrystalline Cellulose and Silicified Microcrystalline Cellulose and for Good Distribution Practice for the central logistic warehouse. The certificate justifies that the Micro cellulose is manufactured and distributed according to the EXCiPACT Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) Certification Standard. The certificate is beneficial for the drug manufacturers to reduce their efforts and costs for performing quality control.

• Oral formulations in the formulations segment have obtained the largest share due to the rise in demand for formulations like tablets, capsules, and oral solutions and suspensions. It is likely to grow with a CAGR of 5.9% in the forecast period.

• Ashland Global Holdings (US), BASF SE (Germany), DuPont (US), Roquette Feres (France), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol Corporation (US), Croda International (UK). Innophous Holdings (US), Kerry Group (Ireland), WACKER Chemie AG (Germany), Colorcon (US), DFE Pharma (Germany), JRS Pharma (Germany), and Air Liquide (France) are the key players in the Pharmaceutical Excipients market

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/2713

For this purpose, Reports and Data have segmented the Pharmaceutical Excipients market on the basis of products, functionality, formulations, end use, and region.

Products Outlook (Revenue in Million USD; (2017–2027)

• Organic Chemicals
o Oleochemicals
 Fatty Alcohols
 Mineral Stearates
 Glycerin
 Other Oleochemicals
o Carbohydrates
 Sugars
 Actual Sugars
 Lactose
 Sucrose
 Dextrose (D-Glucose)
 Sugar Alcohols
 Mannitol
 Sorbitol
 Other Sugar Alcohols
 Artificial Sweeteners
 Cellulose
 Microcrystalline Cellulose
 Cellulose Ethers
 CMC and Croscarmellose Sodium
 Cellulose Esters
 Starch
 Modified Starch
 Dried Starch
 Converted Starch
 Petrochemicals
 Glycols
 Polyethylene Glycol
 Propylene Glycol
 Povidones
 Mineral Hydrocarbons
 Petrolatum
 Mineral Waxes
 Mineral Oils
 Acrylic Polymers
 Other Petrochemicals
 Proteins
 Other Organic Chemicals
o Inorganic Chemicals
 Calcium Phosphate
 Metal Oxides
 Halites
 Calcium Carbonate
 Calcium Sulfate
 Other Inorganic Chemicals
o Others
 Pharmaceutical-Grade Water
 Mucilage

Functionality Outlook (Revenue in Million USD; (2017–2027)

• Fillers and Diluents
• Suspending and Viscosity Agents
• Coating Agents
• Binders
• Flavouring Agents and Sweeteners
• Disintegrates
• Colorants
• Lubricants and Glidants
• Preservatives
• Emulsifying Agents
• Others

Formulations Outlook (Revenue in Million USD; (2017–2027)

• Oral Formulations
o Tablets
o Capsules
 Hard Gelatin Capsules
 Soft Gelatin Capsules
• Liquid Formulations
• Topical Formulations
• Parenteral Formulations
• Others

End Use Outlook (Revenue in Million USD; (2017–2027)

• Pharmaceutical companies
• Chemical companies
• Others

Regional Outlook (Revenue in Million USD; (2017–2027)

• North America
o U.S
o Canada
• Europe
o Germany
o France
o UK
o Spain
o Italy
o Rest of the Europe
• Asia Pacific
o China
o India
o Japan
o Rest of Asia-Pacific
• Middle East & Africa
• Latin America
o Brazil

Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2713

Thank you for reading our report. For customization inquiry or further information, please connect with us and we will ensure you get the report that meets your requirements.

Read More Reports:-

Emergency Ventilator Market @ https://www.google.me/url?q=https://reportsanddata.com/report-detail/emergency-ventilator-market

Infusion Pump Market @ https://www.google.com.fj/url?q=https://reportsanddata.com/report-detail/infusion-pump-market

Contact Us:

John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

This release was published on openPR.